Phase 3 Liver Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 to 75 years old
- People with a general health status rated as fully active or restricted only in physically strenuous activity (confirm with trial site)
- People who have been diagnosed with hepatocellular carcinoma (a type of liver cancer) at a specific mid-to-advanced stage, based on a Chinese liver cancer staging system (confirm with trial site)
- People who have not yet received any treatment for their liver cancer
- People whose cancer cannot currently be removed by surgery, but where a medical team has assessed that surgery may become possible after an initial round of treatment — for example, where multiple tumours are in one lobe of the liver, or where a blood vessel near the liver is affected but could potentially be treated along with the main tumour
- People whose blood and organ function test results meet certain minimum levels (or could meet them with a short course of treatment), covering white blood cells, red blood cells, platelets, liver function, kidney function, and blood clotting (confirm specific values with trial site)
- People who have been fully informed about the study and have signed a consent form
Who may not be able to join:
- People with serious heart, brain, lung, kidney, or other major organ problems, severe infections, or other serious health conditions that would make the treatment too risky
- People who have had another type of cancer at any point
- People with a known history of allergic reactions to the drugs used in this trial
- People with a known allergy to any ingredient in the targeted therapy or immunotherapy drugs used in this trial
- People who have had an organ transplant
- People who have previously received any treatment for liver cancer, including interferon
- People who are HIV-positive
- People with a history of drug abuse
- People who have had a gastrointestinal bleed or a cardiovascular event (such as a heart attack or stroke) within the past 30 days
- Women who are pregnant or breastfeeding, or women of childbearing age who do not wish to use contraception during the trial
- People with a psychiatric condition that would prevent them from giving informed consent or from participating in treatment
- Other factors that may affect a person's participation or the reliability of results (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Wei Wei, Ph.D, M,D, Sun Yat-sen University
Phone: 008615088064187
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
OS
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.